Clinical Trial Update: Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating terlipressin plus albumin versus albumin for hepatorenal syndrome has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatorenal Syndrome

Drugs mentioned

• Albumin
• Terlipressin (terlipressin)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Cirrhosis, Hepatorenal Syndrome | Phase 4 | Status: SUSPENDED